Hainan Huluwa Pharmaceutical Group Co., Ltd.
-
Founded in:
2005-06-22 -
Country:
China -
Address:
No. 8, Yaogu 4th Road, Phase II, Yaogu Industrial Park, Haikou National High-tech Zone, Haikou City, Hainan Province -
Tax NO.:
91460100774262258E -
Registered Funds:
400.108752 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Isosorbide 5-mononitrate |
Relax vascular smooth muscle, reduce myocardial oxygen consumption, and increase coronary perfusion. The specific mechanism includes the release of nitric oxide (NO), activation of guanylate cyclase, and increase of cyclic guanosine monophosphate (cGMP) in smooth muscle cells, thereby dilating peripheral arteries and veins and reducing preload and afterload.
More
Relax vascular smooth muscle, reduce myocardial oxygen consumption, and increase coronary perfusion. The specific mechanism includes the release of nitric oxide (NO), activation of guanylate cyclase, and increase of cyclic guanosine monophosphate (cGMP) in smooth muscle cells, thereby dilating peripheral arteries and veins and reducing preload and afterload. |
16051-77-7 | 23 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ribavirin |
A synthetic nucleoside antiviral drug that selectively inhibits respiratory syncytial virus (RSV) and may act as a metabolic analog of guanosine and xanthine nucleosides.
More
A synthetic nucleoside antiviral drug that selectively inhibits respiratory syncytial virus (RSV) and may act as a metabolic analog of guanosine and xanthine nucleosides. |
36791-04-5 | 33 |